{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:51:02Z","timestamp":1788187862344,"version":"build-2803163510"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Owing to their continuous evolution, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) display disparate pathogenicity in mouse models. Omicron and its sublineages have been dominant worldwide. Compared to pre-Omicron VOCs, early Omicron subvariants reportedly cause attenuated disease in human ACE-2-expressing mice (K18-hACE-2). In late 2022, the frequency of Omicron subvariant XBB.1.5 rapidly increased and it progressively replaced other circulating strains. The emergence of new strains requires current SARS-CoV-2 clinical animal model re-evaluation. In this study, we aim to characterize XBB.1.5 pathogenesis in K18-hACE-2. Herein, we demonstrated that XBB.1.5 infection is associated with significant weight loss, severe lung pathology, and substantial mortality. Intranasal XBB.1.5 infection resulted in 100% mortality in K18-hACE2 mice. High virus titers were detected in the lungs on days 3 and 5 after infection. Moreover, XBB.1.5 productively infected the cells within the nasal turbinate, olfactory bulb, intestines, and kidneys. In addition, in a subset of infected mice, we detected high virus titers in the brain. Consistently, we detected high viral antigen expression in the lungs. Furthermore, we observed severe lung injury hallmarks (e.g., immune cell infiltration, perivascular cuffing, and alveolar consolidation). Using immunofluorescence labeling and cytometric analysis, we revealed that XBB.1.5 infection leads to CD45<jats:sup>+<\/jats:sup> cell influx into the lung parenchyma. We further demonstrated that most immune infiltrates are CD11b<jats:sup>+<\/jats:sup> CD11c<jats:sup>+<\/jats:sup> dendritic cells. Additionally, we detected significant induction of proinflammatory cytokines and chemokines in infected lungs. Taken together, our data show that Omicron subvariant XBB.1.5 is highly pathogenic in K18-hACE2 mice.<\/jats:p>","DOI":"10.3389\/fmicb.2024.1466980","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T04:54:23Z","timestamp":1727844863000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice"],"prefix":"10.3389","volume":"15","author":[{"given":"Amany","family":"Elsharkawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchala","family":"Guglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila D.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinonye","family":"Dim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Miano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1275823","DOI":"10.3389\/fcimb.2023.1275823","article-title":"The critical role of interleukin-6 in protection against neurotropic flavivirus infection","volume":"13","author":"Auroni","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1038\/s41564-024-01726-6","article-title":"mRNA-encoded Cas13 can be used to treat dengue infections in mice","volume":"9","author":"Basu","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients with coronavirus disease 2019","volume":"71","author":"Chen","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"101401","DOI":"10.1016\/j.beha.2022.101401","article-title":"COVID-19 disease and immune dysregulation","volume":"35","author":"Davitt","year":"2022","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e0096421","DOI":"10.1128\/JVI.00964-21","article-title":"The K18-human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-CoV-2 virus","volume":"96","author":"Dong","year":"2022","journal-title":"J. Virol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","article-title":"SARS-CoV-2 omicron variant: recent progress and future perspectives","volume":"7","author":"Fan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00134-020-06153-9","article-title":"Acute kidney injury in critically ill patients with COVID-19","volume":"46","author":"Gabarre","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00335-022-09943-2","article-title":"Of mice and human-specific long noncoding RNAs","volume":"33","author":"Ghanam","year":"2022","journal-title":"Mamm. Genome"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","article-title":"SARS-CoV-2 omicron virus causes attenuated disease in mice and hamsters","volume":"603","author":"Halfmann","year":"2022","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"10224","DOI":"10.3390\/ijms231810224","article-title":"ZBP1: a powerful innate immune sensor and double-edged sword in host immunity","volume":"23","author":"Hao","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 omicron variant replication in human respiratory tract ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.4110\/in.2021.21.e32","article-title":"SARS-COV-2 delta (B.1.617.2) variant: a unique T478K mutation in receptor binding motif (RBM) of spike gene","volume":"21","author":"Jhun","year":"2021","journal-title":"Immune Netw."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"eabo6294","DOI":"10.1126\/sciimmunol.abo6294","article-title":"ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection","volume":"7","author":"Karki","year":"2022","journal-title":"Sci. Immunol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/jmv.27526","article-title":"Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein","volume":"94","author":"Kumar","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/v13010132","article-title":"Neuroinvasion and encephalitis following intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice","volume":"13","author":"Kumari","year":"2021","journal-title":"Viruses"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41591-022-02162-x","article-title":"Low neutralization of SARS-CoV-2 omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster","volume":"29","author":"Kurhade","year":"2023","journal-title":"Nat. Med."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41422-022-00775-y","article-title":"SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses","volume":"33","author":"Li","year":"2023","journal-title":"Cell Res."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"701501","DOI":"10.3389\/fimmu.2021.701501","article-title":"SARS-CoV-2 vaccines based on the spike glycoprotein and implications of new viral variants","volume":"12","author":"Mart\u00ednez-Flores","year":"2021","journal-title":"Front. Immunol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J. Virol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3390\/v14061139","article-title":"Differential pathogenesis of SARS-CoV-2 variants of concern in human ACE2-expressing mice","volume":"14","author":"Natekar","year":"2022","journal-title":"Viruses"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3390\/pathogens13070528","article-title":"Upregulation of Neuroinflammation-associated genes in the brain of SARS-CoV-2-infected mice","volume":"13","author":"Oh","year":"2024","journal-title":"Pathogens"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"19176","DOI":"10.1038\/s41598-023-46025-y","article-title":"XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants","volume":"13","author":"Patel","year":"2023","journal-title":"Sci. Rep."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1099\/vir.0.040899-0","article-title":"West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases","volume":"93","author":"Roe","year":"2012","journal-title":"J. Gen. Virol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/s41467-021-21239-8","article-title":"Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody","volume":"12","author":"Rosenfeld","year":"2021","journal-title":"Nat. Commun."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/pathogens11020257","article-title":"SARS-CoV-2 infects primary neurons from human ACE2 expressing mice and upregulates genes involved in the inflammatory and necroptotic pathways","volume":"11","author":"Rothan","year":"2022","journal-title":"Pathogens"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/S1473-3099(23)00690-4","article-title":"Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination","volume":"24","author":"Stankov","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1320856","DOI":"10.3389\/fmicb.2023.1320856","article-title":"SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids","volume":"14","author":"Stewart","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/v14010027","article-title":"SARS-CoV-2 variants of concern infect the respiratory tract and induce inflammatory response in wild-type laboratory mice","volume":"14","author":"Stone","year":"2021","journal-title":"Viruses"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/22221751.2020.1760144","article-title":"Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient","volume":"9","author":"Sun","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S1473-3099(22)00816-7","article-title":"Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB BQ.1.1 and XBB","volume":"23","author":"Uraki","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S1473-3099(23)00051-8","article-title":"Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant XBB.1.5 variant","volume":"23","author":"Uriu","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e0084422","DOI":"10.1128\/jvi.00844-22","article-title":"An S1-nanoparticle vaccine protects against SARS-CoV-2 challenge in K18-hACE2 mice","volume":"96","author":"van Oosten","year":"2022","journal-title":"J. Virol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chom.2024.01.014","article-title":"XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1","volume":"32","author":"Wang","year":"2024","journal-title":"Cell Host Microbe"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e137799","DOI":"10.1172\/jci.insight.137799","article-title":"The laboratory tests and host immunity of COVID-19 patients with different severity of illness","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e070695","DOI":"10.1136\/bmj-2022-070695","article-title":"Risk of Covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study","volume":"378","author":"Ward","year":"2022","journal-title":"BMJ"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","author":"Winkler","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"103812","DOI":"10.1016\/j.ebiom.2022.103812","article-title":"Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs","volume":"75","author":"Won","year":"2022","journal-title":"EBioMedicine"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.3201\/eid2608.200681","article-title":"Infectious SARS-CoV-2 in feces of patient with severe COVID-19","volume":"26","author":"Xiao","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S1473-3099(23)00010-5","article-title":"ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5 of XBB.1.5","volume":"23","author":"Yue","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/CIRCULATIONAHA.123.063760","article-title":"INKILN is a novel long noncoding RNA promoting vascular smooth muscle inflammation via scaffolding MKL1 and USP10","volume":"148","author":"Zhang","year":"2023","journal-title":"Circulation"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","article-title":"Heightened innate immune responses in the respiratory tract of COVID-19 patients","volume":"27","author":"Zhou","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1466980\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T04:54:24Z","timestamp":1727844864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1466980\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":48,"alternative-id":["10.3389\/fmicb.2024.1466980"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1466980","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"article-number":"1466980"}}